PLUS THERAPEUTICS, INC.

PSTV · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus
427
SEC Filings

Business Summary

PART I Item 1. B usiness References to Plus Therapeutics, the Company, we, us and our refer to Plus Therapeutics, Inc. References to Notes refer to the Notes to Financial Statements included herein (refer to Item 8). General Plus Therapeutics is a U.S. healthcare company developing and commercializing precision diagnostics and targeted radiopharmaceuticals for central nervous system (CNS) cancers. CNSide Diagnostics, LLC (CNSide Diagnostics) is our wholly owned subsidiary that develops and comme...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPSTVdiscussed_in_filing Cybersecurity
topic_mentionPSTVdiscussed_in_filing Cybersecurity
topic_mentionPSTVdiscussed_in_filing Healthcare & Bio
topic_mentionPSTVdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-104258EDGAR87K words
2025-03-312024-12-310000950170-25-047698EDGAR—
2024-03-052023-12-310000950170-24-025851EDGAR—
2023-02-232022-12-310000950170-23-004099EDGAR—
2022-02-242021-12-310001564590-22-006708EDGAR—
2021-02-222020-12-310001564590-21-007165EDGAR—
2020-03-302019-12-310001564590-20-014165EDGAR—
2019-03-292018-12-310001564590-19-010018EDGAR—
2018-03-092017-12-310001564590-18-005136EDGAR—
2017-03-242016-12-310001564590-17-005251EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001193125-25-258596EDGAR37K words
2025-08-142025-06-300000950170-25-108874EDGAR—
2025-05-302025-03-310000950170-25-079738EDGAR—
2024-11-142024-09-300000950170-24-127014EDGAR—
2024-08-142024-06-300000950170-24-097091EDGAR—
2024-05-152024-03-310000950170-24-060395EDGAR—
2023-10-312023-09-300000950170-23-056844EDGAR—
2023-08-142023-06-300000950170-23-042363EDGAR—
2023-04-202023-03-310000950170-23-013671EDGAR—
2022-10-202022-09-300000950170-22-019798EDGAR—
2022-07-212022-06-300001564590-22-026156EDGAR—
2022-04-212022-03-310001564590-22-015075EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001193125-26-140267EDGAR1K words
2026-03-260001193125-26-125195EDGAR—
2026-03-120001193125-26-104291EDGAR—
2026-03-120001193125-26-104218EDGAR—
2026-02-130001193125-26-051379EDGAR—
2026-01-220001193125-26-018675EDGAR—
2026-01-160001193125-26-015346EDGAR—
2025-11-170001193125-25-283935EDGAR—
2025-10-300001193125-25-258568EDGAR—
2025-10-210001193125-25-244275EDGAR—

427 total filings indexed. 395 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Company Identity

CIK0001095981
TickerPSTV
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fc6df9c42b0349773cf45fea4797c1174c5284a51e99b18c629a3ba0611f3dcc
parent: f1e05eddb508ef9fce3f44df6457118a786401c5bfe21ea43c61a21e865a0adb
content hash: b5a9ddcb893d5ad373ca3c9e9f81a4db9ff0fb3384f0c767f1aa4767e326f0be
signed: 2026-04-13T04:47:02.249Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf